The Intel split.
Stratechery discusses Intel on the heels of its becoming a customer of competitor TSMC. | learn more
Stratechery discusses Intel on the heels of its becoming a customer of competitor TSMC. | learn more
From a customer and shareholder. “Shopify stock is down 50% over the past 12 months. Its mission may be to “arm the rebels,” but it is giving us muskets in a war that is increasingly being fought with machine guns.“ | learn […]
“I’ve also come to believe that if you’re going to get on the fundraising train, it’s important to plan for enough capital to get to a scale that provides for some exit opportunities in the event the business doesn’t achieve […]
This link came to me by chance, and I was thrilled to see it hosted on my friend’s site DailyIdea.com! “Any time you can think of something that is possible this year and wasn’t possible last year, you should pay […]
It’s interesting that to have a shot at replacing SQL, the new language has to build on top of it. “Malloy is a language for anyone who works with SQL–whether you’re an analyst, data scientist, data engineer, or someone building […]
“This piece undertakes a daunting set of tasks: 1) understand what Microsoft is, 2) chart a path for its global domination, and 3) apply learnings from the company to the startup ecosystem.” | learn more
I heard Stella Garber allude to this on a podcast interview and had to look it up. The company publishes some content describing the system (to attract engineers) and it sounds impressive. “[BigBrain] tracks every single KPI we have here at monday.com.” | learn […]
So says Parker Conrad, founder of Rippling and of Zenefits, in this video interview. The traditional advice to founders is to narrow scope and focus to create a fighting chance to succeed. He makes the case for why startups with […]
“Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain.” This article in Scientific American profiles the billionaire-backed Calico Life Sciences, Life Biosciences, and Turn Biotechnologies. | learn more
“If innovative reactor designs can’t pass muster with the federal government, the U.S. nuclear industry is in trouble.” | learn more